Background
==========

Early revascularization in the setting of acute myocardial infarction complicated by cardiogenic shock improves 6-month survival. In the absence of available data on the long-term outcome (more than 16 months) of this strategy, we studied the 5-year outcome in a consecutive group of patients undergoing percutaneous transluminal coronary angioplasty (PTCA) in cardiogenic shock due to myocardial ischemia.

Methods
=======

The study period covers 1986--2002. The survival status on March 2003 was available for all 123 patients. The median follow-up was 4.7 years. The mean age was 64 ± 10 years. Major comorbidities were diabetes (15%), peripheral vascular disease (18%), cerebrovascular disease (13%), renal failure (18%), and chronic pulmonary disease (10%). Nineteen per cent had previous coronary artery bypass grafting (CABG), 11% previous PTCA. Myocardial infarction occurred within less than 7 days in 80% and less than 24 hours in 60%. One vessel was treated in 83% of the cases. The ratio of stented segments was 0.56. The success/segment was 84%. Full procedural success was obtained in 80%, incomplete success in 4%. Sixteen per cent of the attempts failed.

Results
=======

Inhospital mortality was 54%. Inhospital major adverse events (death, CABG, myocardial infarction) occurred in 62%. Survival at 1 year and 5 years was 41 ± 4% and 40 ± 4% (NS), respectively. Survival at 5 years after a successful procedure was 44 ± 5% versus 17 ± 8% after incomplete success/failure (*P*\< 0.001). Multivariate analysis showed four independent variables for the long-term outcome: age, left ventricular dysfunction, extent of coronary artery disease and procedural result.

Conclusions
===========

\(1\) Survivors at hospital discharge after PTCA in cardiogenic shock have an excellent long-term outcome. (2) The favourable impact of successful PTCA procedures and the excellent long-term outcome of hospital survivors are strong arguments in favour of an \'invasive\' approach in the presence of cardiogenic shock.
